Only two listed contraindications are found within the 2008 package insert: * "Nonsteroidal anti-inflammatory drugs (NSAIDs): Although not observed with<unk>  in preclinical and clinical trials, the concomitant administration of a nonsteroidal anti-inflammatory drug with a fluoroquinolone may increase the risks of CNS stimulation and convulsions." *<unk>  is contraindicated in persons with a history of hypersensitivity to<unk> , any member of the quinolone class of antimicrobial agents, or any of the product components." Though not stated as such within the package insert, ziprasidone is also considered to be contraindicated, as it may have the potential to prolong QT interval.<unk>  should also be avoided in patients with uncorrected hypokalemia, or concurrent administration of other medications known to prolong the QT interval (antipsychotics and tricyclic antidepressants).<unk>  should be used with caution in patients suffering from diabetes, as glucose regulation may be significantly altered.<unk>  is also considered to be contraindicated within the pediatric population, pregnancy, nursing mothers, patients with a history of tendon disorder, patients with documented QT prolongation, and patients with epilepsy or other seizure disorders. Coadministration of<unk>  with other drugs that also prolong the QT interval or induce bradycardia (e.g., beta-blockers, amiodarone) should be avoided. Careful consideration should be given in the use of<unk>  in patients with cardiovascular disease, including those with conduction abnormalities. Children and adolescents The safety of<unk>  in human patients under age 18 has not been established. Animal studies suggest a risk of musculoskeletal harm in juveniles.
Moxifloxacin
Telithromycin
Azithromycin
Dirithromycin
Roxithromycin
Amikacin
Gemifloxacin
Levofloxacin